Pregnancy and fertility registry for people with breast cancer
Part of Cancer, Skin clinical trials.
This trial is a registry that collects information about pregnancy and future fertility in people with breast cancer. It may help doctors better understand outcomes and care options for patients in these situations by studying real-world experiences.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with breast cancer
- You can give written consent (sign a consent form)
- Your situation fits one of these timeframes: pregnant with breast cancer, breast cancer during pregnancy or within 1 year after, or pregnancy after breast cancer treatment
- For fertility-focused participants: you are age 18–45
- For fertility-focused participants: you have not had chemotherapy or radiation for cancer before joining
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows women who have had cancer or a blood disorder and chose to preserve their fertility before treatment. Researchers want to see how well these preservation methods work over time.
This study helps people with cancer preserve their fertility (ability to have biological children) before undergoing cancer treatment that could affect their eggs or sperm. The trial compares two different hormone-injection methods to prepare eggs for freezing.
This trial tests a telehealth (video/phone) program that helps adolescents and young adults with cancer plan for future fertility. It may help you get support and options for preserving your ability to have children before cancer treatment affects it.
This study provides a smartphone-based platform to help women with early-stage gynecologic cancers learn about and plan for preserving their fertility before starting treatment. It aims to support decision-making and emotional well-being during a challenging time.
This registry collects information from pre- or perimenopausal women with early breast cancer who are treated with standard care, plus tumor testing like MammaPrint®. It may help doctors better understand which treatments work best for different risk groups.
This study helps women with cancer keep their ability to have children after treatment. It offers egg or embryo freezing and checks on pregnancy and baby health later on.
Hear when a new Breast Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.